%0 Journal Article %T Correction: Anti-PD-L1 (atezolizumab) as an immune primer and concurrently with extended-field chemoradiotherapy for node-positive locally advanced cervical cancer %D 2020 %R 10.1136/ijgc-2019-001012corr2 %J International Journal of Gynecologic Cancer %P 1266-1266 %V 30 %N 8 %U https://ijgc.bmj.com/content/ijgc/30/8/1266.full.pdf